Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,925 | -$26,732 | -$24,063 | -$19,980 |
| Dep. & Amort. | $256 | $252 | $244 | $260 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4,389 | $4,040 | $3,208 |
| Change in WC | $3,698 | -$3,370 | -$433 | $1,341 |
| Other Non-Cash | $5,506 | $391 | -$25 | $725 |
| Operating Cash Flow | -$17,465 | -$25,070 | -$20,237 | -$14,446 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$134 | -$22 | -$291 | -$226 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$101,620 | -$12,950 | -$43,671 | -$84,559 |
| Inv. Sales/Matur. | $44,978 | $35,476 | $64,557 | $116,715 |
| Other Inv. Act. | $0 | $92 | $436 | $0 |
| Investing Cash Flow | -$56,776 | $22,596 | $21,031 | $31,930 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $270,533 | -$63 | $6 | $0 |
| Stock Repurch. | $0 | $0 | -$1 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $7 |
| Financing Cash Flow | $270,533 | -$63 | $5 | $7 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $196,292 | -$2,537 | $799 | $17,491 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55,172 | $57,709 | $56,910 | $39,419 |
| End Cash | $251,464 | $55,172 | $57,709 | $56,910 |
| Free Cash Flow | -$17,599 | -$25,092 | -$20,528 | -$14,672 |